Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Sales | 1,660 | 1,680 | 2,780 | 2,020 | 1,230 |
| Cost of Goods | 40 | 130 | N/A | N/A | N/A |
| Gross Profit | 1,610 | 1,540 | 2,780 | 2,020 | 1,230 |
| Operating Expenses | 1,190 | 3,610 | 3,700 | 2,540 | 620 |
| Operating Income | 470 | -1,930 | -920 | -520 | 610 |
| Interest Expense | 100 | 80 | 20 | 10 | 30 |
| Other Income | -10 | -3,740 | -3,710 | -24,550 | -3,750 |
| Pre-tax Income | 360 | -5,750 | -4,650 | -25,080 | -3,170 |
| Income Tax | 7 | 30 | 60 | 310 | 60 |
| Net Income Continuous | 353 | -5,780 | -4,710 | -25,390 | -3,230 |
| Net Income | $350 | $-5,790 | $-4,710 | $-25,390 | $-3,240 |
| EPS Basic Total Ops | 229,477.10 | -4,166,522.00 | -4,158,441.00 | -2,084,961.00 | N/A |
| EPS Basic Continuous Ops | 231,444.00 | -4,159,326.00 | -4,158,441.00 | -2,084,961.00 | N/A |
| EBITDA(a) | $570 | $-1,810 | $-520 | $-390 | $680 |